A Retrospective Cohort Analysis of Analgosedation Requirements in COVID-19 Compared to Non-COVID-19 Extracorporeal Membrane Oxygenation Patients.
Alyssa M SchallerJoel T FeihJanelle J JuulLisa E ReinBrittney E DuewellHemanckur MakkerPublished in: Journal of intensive care medicine (2024)
COVID-19 patients on ECMO had significantly longer durations and higher doses of propofol, dexmedetomidine, and parenteral opioids over the first 28 days of cannulation. The only interventions that were associated with statistical reductions in propofol were antipsychotics and tracheostomy.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- sars cov
- coronavirus disease
- respiratory failure
- end stage renal disease
- mechanical ventilation
- newly diagnosed
- chronic kidney disease
- prognostic factors
- physical activity
- peritoneal dialysis
- respiratory syndrome coronavirus
- pain management
- patient reported outcomes
- cardiac surgery
- intensive care unit
- acute kidney injury